Immunological methods and materials for detection of tumor associated antigens
 Disclosed are immunological methods and materials for detection of antigens associated with breast or prostate cancer disease states. Presently preferred antibody preparations (e.g., PR92 monoclonal antibodies produced by hybridoma cell line ATCC HB 9390) are employed in immunoassays performed on patient body fluids and for purification of tumor-associated antigen compositions. 
Abbott Laboratories
Y Y Y C Y C
Y10S Y10S Y10S C07K Y10S C07K
additional additional additional inventional additional inventional
Yung D.
Kim